Sign in
4

Changes in Ownership

ProQR Therapeutics N.V. Filed Acc 0001104659-26-085234

Director bought 150,000 shares at $1.72 ($257,925)

From the SEC's structured data for this filing

Trades in this filing

Filius Bart · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-17 Purchase : show line 1 in the form +150,000 $1.72 $257,925 300,000 D
Open-market purchases · 150,000 sh · avg $1.72 · $257,925
Loading xslF345X06/tm2620903-1_4seq1.xml…